5-bromo-2-fluoro-3-methylpyridine | CAS:29312-98-9

We serve 5-bromo-2-fluoro-3-methylpyridine CAS:29312-98-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-bromo-2-fluoro-3-methylpyridine

Chemical Name:5-bromo-2-fluoro-3-methylpyridine
CAS.NO:29312-98-9
Synonyms:5-bromo-2-fluoro-3-methylpyridine
2-fluoro-5-bromo-3-methylpyridine
5-bromo-2-fluoro-3-methyl-pyridine
2-fluoro-5-bromo-3-picoline
2-FLUORO-3-METHYL-5-BROMOPYRIDINE
Molecular Formula:C6H5BrFN
Molecular Weight:190.01300
 
Physical and Chemical Properties:
Density:1.592
Melting point:60-63ºC
Boiling point:205.4ºC
Flash point:78ºC
Index of Refraction:1.529
 
Specification:
Appearance:White solid
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 5-bromo-2-fluoro-3-methylpyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-FLUORO-3-METHYL-5-BROMOPYRIDINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-bromo-2-fluoro-3-methylpyridine Use and application,5-bromo-2-fluoro-3-methyl-pyridine technical grade,usp/ep/jp grade.


Related News: f you’ve traveled in or transited through mainland China, you won’t be allowed into New Zealand unless you’re a New Zealand national.2,7-Dibromo-9H-fluoren-9-one manufacturer With the onset of the DMF system for APIs, the concentration of the API industry will further increase.2,3-Diethyl-5-methylpyrazine supplier Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.3-Fluoro-2-Formylphenylboronic Acid vendor The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.Taiwan previously participated as an observer at the World Health Assembly, the W.H.O.’s governing body.